Pintu Kanjilal

Scientist, LNP Discovery, Strand Therapeutics

Pintu Kanjilal is a formulation scientist specializing in lipid nanoparticles and targeted nanomedicine for mRNA therapeutics. At Strand Therapeutics, he develops and optimizes LNP systems for improved delivery and tumor-specific expression. His background spans polymer chemistry, bioconjugation, and drug delivery, with a PhD from UMass Amherst focused on nanoparticle-based targeting strategies.

Seminars

Wednesday 18th November 2026
Quantify Targeting Ligand Conjugation Efficiency & Surface Density
4:10 pm
  • Measure percent conjugated particles versus free particles, determine antibody or peptide density per LNP, assess conjugation uniformity
  • Identify conjugation sites and ligand orientation, understand impact on targeting efficiency, optimize conjugation chemistry
  • Develop potency assays that reflect binder function, correlate to in vivo targeting, predict clinical performance
Pintu Kanjilal
View all Speakers
View Event Brochure